JNK inhibitors for treatment of CNS injury

Details for Australian Patent Application No. 2005309732 (hide)

Owner Celgene Corporation

Inventors Manning, Donald; Faleck, Herbert; Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005309732

PCT Pub. Number WO2006/058007

Priority 60/630,598 23.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/058007 Priority application(s): WO2006/058007

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309733-Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury

2005309725-Separator for multi-phase slug flow and method of designing same